Community Care Team Workshops: New Frontline Strategies Challenge Longtime Standards in DLBCL

Download this slideset from a local live webinar to learn how to optimally manage your patients with DLBCL.

In this commentary, I will address how diffuse large B cell lymphoma looks at presentation, discuss how current frontline treatment varies among patient subgroups, and review recent data supporting polatuzumab vedotin plus R-CHP as an improvement vs R-CHOP.

Brad S. Kahl, MD Released: March 3, 2022

Watch this on-demand webcast capturing a dynamic workshop led by an expert on multidisciplinary management of patients with DLBCL in the frontline setting, including incorporating novel treatment paradigms into the standard of care.

Jeremy S. Abramson, MD, MMSc
Program Director John M. Burke, MD
Program Director Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: September 13, 2022 Expired: No longer available for credit